::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

FACTORS ASSOCIATED WITH PROGRESSION TO CRITICAL ILLNESS IN COVID-19 PATIENTS

AUTHORS:

Dr Javeria Rahim, Dr Sumbal Javaid, Dr Afshan Jabeen

ABSTRACT:

Introduction: The world has witnessed a rapid escalation of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and it has become a global pandemic since March 2020. Objectives: The main objective of the study is to analyse the factors associated with progression to critical illness in COVID-19 patients. Material and methods: This cross sectional study was conducted in Islamic International Medical College during January 2020 to June 2020. The data was collected from confirmed COVID-19 patients. Subjects who met eligibility criteria were referred by their treating physicians. Results: The data was collected from 200 confirmed COVID-19 patients. The most common self-reported symptoms at onset of illness were fever, cough, fatigue, sputum production, anorexia, and dyspnea. A total of 116 patients had typical abnormal findings on chest CT, with a median lung CT score of 6. Sixty-nine patients were identified as having severe or critical pneumonia. Conclusion: It is concluded that COVID-19 is a fast-evolving, global pandemic with a higher risk of severe or critical illnesses in individuals who are older, have underlying hypertension.